PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0378/2023 : EMA decision of 8 September 2023 on the acceptance of a modification of an agreed paediatric investigation plan for fremanezumab (Ajovy), (EMEA-001877-PIP01-15-M04)